June 5, 2019
Pillet S et al. PLoS One 2019;14(6):e0216533.
Immunogenicity and Safety of a Quadrivalent Plant-derived Virus Like Particle Influenza Vaccine Candidate – Two Randomized Phase II Clinical Trials in 18 to 49 and ≥50 Years Old Adults
You might also be interested by
Brochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More infoInfographics
Advance Your Cell Therapy - with our cross-platform capabilities
November 5, 2021
Histopathology
More info